SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020269
Filing Date
2024-06-14
Accepted
2024-06-14 08:00:40
Documents
22
Period of Report
2024-06-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20240613_8k.htm   iXBRL 8-K 27151
2 EXHIBIT 99.1 ex_688103.htm EX-99.1 19880
3 EXHIBIT 99.2 ex_688104.htm EX-99.2 1485
8 dor.jpg GRAPHIC 36417
9 m02.jpg GRAPHIC 47154
10 mbrx20240613_8kimg001.jpg GRAPHIC 5067
11 mole.jpg GRAPHIC 4957
12 rgm.jpg GRAPHIC 56155
13 slide1.jpg GRAPHIC 252165
  Complete submission text file 0001437749-24-020269.txt   748548

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240614.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240614_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240614_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240614_pre.xml EX-101.PRE 11584
25 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240613_8k_htm.xml XML 2834
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 241043181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)